Theophylline

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 42291-922
  • Package NDC 42291-922-01
  • Application number ANDA089763
  • SPL ID 48bf9d36-1151-79d1-e063-6394a90aee09
  • SPL set ID f93e20b1-97aa-088d-e053-6394a90a25d4
  • UNII 0I55128JYK
  • RxCUI 317769

What the source publishes

Labeler
AvKARE
Active ingredients
Theophylline
Form
TABLET, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:42291-922_48bf9d36-1151-79d1-e063-6394a90aee09
{
  "name": "Theophylline",
  "splId": "48bf9d36-1151-79d1-e063-6394a90aee09",
  "labels": [
    {
      "setId": "f93e20b1-97aa-088d-e053-6394a90a25d4",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f93e20b1-97aa-088d-e053-6394a90a25d4",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f93e20b1-97aa-088d-e053-6394a90a25d4"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "AvKARE",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-922-01)",
      "package_ndc": "42291-922-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230413"
    }
  ],
  "productId": "42291-922_48bf9d36-1151-79d1-e063-6394a90aee09",
  "useDomain": "unknown",
  "dosageForm": "TABLET, EXTENDED RELEASE",
  "productNdc": "42291-922",
  "deaSchedule": null,
  "genericName": "Theophylline",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "THEOPHYLLINE ANHYDROUS",
      "strength": "300 mg/1"
    }
  ],
  "applicationNumber": "ANDA089763",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20230413",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175790",
      "M0023046"
    ],
    "upc": [
      "0342291922013"
    ],
    "unii": [
      "0I55128JYK"
    ],
    "rxcui": [
      "317769"
    ],
    "spl_set_id": [
      "f93e20b1-97aa-088d-e053-6394a90a25d4"
    ],
    "pharm_class_cs": [
      "Xanthines [CS]"
    ],
    "pharm_class_epc": [
      "Methylxanthine [EPC]"
    ],
    "manufacturer_name": [
      "AvKARE"
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:42291-922_48bf9d36-1151-79d1-e063-6394a90aee09"